Literature DB >> 29518465

In vitro and ex vivo correlation of drug release from ophthalmic ointments.

Quanying Bao1, Bryan Newman2, Yan Wang2, Stephanie Choi2, Diane J Burgess3.   

Abstract

In vitro drug release testing and ex vivo transcorneal drug permeation can provide valuable information on the performance of the Q1/Q2 equivalent ointments prior to any animal studies. Good correlation between in vitro and ex vivo drug release may be indicative of good in vitro and in vivo correlation. Accordingly, it is important to investigate in vitro as well as ex vivo drug release from Q1/Q2 equivalent ophthalmic ointments and evaluate whether a correlation between these release profiles can be established. Four Q1/Q2 equivalent loteprednol etabonate ointments were prepared using different processing methods and excipient sources. The rheological parameters (crossover modulus and K value) of the four formulations were determined. The in vitro drug release testing of the four ointment formulations were performed using three different apparati (Franz diffusion cells, USP apparatus 2 with enhancer cells and USP apparatus 4 with semisolid adapters). Three models (zero order, logarithmic and the Higuchi model) were used to study the release kinetics of the ointment formulations. The transcorneal (rabbit corneas) permeation studies were performed using spherical joint Franz diffusion cells. The USP apparatus 4 method demonstrated better discriminatory ability compared to the USP apparatus 2 and the Franz diffusion cell methods. The in vitro release profiles of the four Q1/Q2 equivalent ointments with manufacturing differences showed a better fit using the Higuchi model (R2 > 0.98) for all three release testing methods, compared to the other two models. Ex vivo drug release through the rabbit corneas displayed zero order release kinetics. A logarithmic correlation between rheological parameters (crossover and K value) and transcorneal flux were established. In addition, a plot of the in vitro release rate against the ex vivo release flux of the four ointment formulations, yielded a straight line (R2 > 0.98) for all three release methods. Accordingly, the rheological parameters may be useful in predicting in vitro as well as ex vivo release properties.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ex vivo; Franz diffusion cells; Hydroxypropyl-beta-cyclodextrin; In vitro; Lotemax; Ophthalmic ointment; Rabbit corneas; Transcorneal

Mesh:

Substances:

Year:  2018        PMID: 29518465      PMCID: PMC6681454          DOI: 10.1016/j.jconrel.2018.03.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  8 in total

Review 1.  Perspectives on Physicochemical and In Vitro Profiling of Ophthalmic Ointments.

Authors:  Quanying Bao; Diane J Burgess
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

Review 2.  In vitro dissolution testing models of ocular implants for posterior segment drug delivery.

Authors:  Muhammad Faris Adrianto; Febri Annuryanti; Clive G Wilson; Ravi Sheshala; Raghu Raj Singh Thakur
Journal:  Drug Deliv Transl Res       Date:  2021-08-11       Impact factor: 5.671

3.  Sensitivity of Different In Vitro Performance Tests and Their In Vivo Relevance for Calcipotriol/Betamethasone Ointment.

Authors:  Nina Habjanič; Mojca Kerec Kos; Katja Kristan
Journal:  Pharm Res       Date:  2020-02-10       Impact factor: 4.200

4.  In Vitro Release Testing of Acyclovir Topical Formulations Using Immersion Cells.

Authors:  Madhur Kulkarni; Shrikant Potdar; Abhijit A Date; Aditya Marfatiya
Journal:  Assay Drug Dev Technol       Date:  2020-10-09       Impact factor: 1.738

5.  Impact of Formulation Parameters on In Vitro Release from Long-Acting Injectable Suspensions.

Authors:  Quanying Bao; Yuan Zou; Yan Wang; Stephanie Choi; Diane J Burgess
Journal:  AAPS J       Date:  2021-03-11       Impact factor: 4.009

6.  Ciprofloxacin self-dissolvable Soluplus based polymeric films: a novel proposal to improve the management of eye infections.

Authors:  Antonio J Guillot; Dimitris Petalas; Pari Skondra; Hortensia Rico; Teresa M Garrigues; Ana Melero
Journal:  Drug Deliv Transl Res       Date:  2021-02-02       Impact factor: 4.617

Review 7.  In vitro Model Systems for Studies Into Retinal Neuroprotection.

Authors:  Yu Zhu; Bowen Cao; Arianna Tolone; Jie Yan; Gustav Christensen; Blanca Arango-Gonzalez; Marius Ueffing; François Paquet-Durand
Journal:  Front Neurosci       Date:  2022-07-07       Impact factor: 5.152

8.  Influence of Concentration on Release and Permeation Process of Model Peptide Substance-Corticotropin-From Semisolid Formulations.

Authors:  Wioletta Siemiradzka; Barbara Dolińska; Florian Ryszka
Journal:  Molecules       Date:  2020-06-15       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.